These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33474640)

  • 1. A Patient Portal-Based Commitment Device to Improve Adherence with Screening for Colorectal Cancer: a Retrospective Observational Study.
    Hahn EE; Baecker A; Shen E; Haupt EC; Wakach W; Ahuja A; Imley TM; Gould MK; Kanter M
    J Gen Intern Med; 2021 Apr; 36(4):952-960. PubMed ID: 33474640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
    Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
    JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal Cancer Screening After Sequential Outreach Components in a Demographically Diverse Cohort.
    Podmore C; Selby K; Jensen CD; Zhao WK; Weiss NS; Levin TR; Schottinger J; Doubeni CA; Corley DA
    JAMA Netw Open; 2024 Apr; 7(4):e245295. PubMed ID: 38625704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health plan-based mailed fecal testing for colorectal cancer screening among dual-eligible Medicaid/Medicare enrollees: Outcomes of 2 program models.
    Baldwin LM; Coronado GD; West II; Schwartz MR; Meenan RT; Vollmer WM; Petrik AF; Shapiro JA; Kulkarni-Sharma YR; Green BB
    Cancer; 2022 Jan; 128(2):410-418. PubMed ID: 34586630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
    Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
    J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial.
    O'Connor EA; Vollmer WM; Petrik AF; Green BB; Coronado GD
    Trials; 2020 Jan; 21(1):91. PubMed ID: 31941527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for Medicaid beneficiaries at a large county health department: A randomized controlled trial.
    Brenner AT; Rhode J; Yang JY; Baker D; Drechsel R; Plescia M; Reuland DS; Wroth T; Wheeler SB
    Cancer; 2018 Aug; 124(16):3346-3354. PubMed ID: 30004577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers.
    Baker DW; Brown T; Goldman SN; Liss DT; Kollar S; Balsley K; Lee JY; Buchanan DR
    Cancer Causes Control; 2015 Nov; 26(11):1685-90. PubMed ID: 26337733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing.
    Selby K; Jensen CD; Levin TR; Lee JK; Schottinger JE; Zhao WK; Corley DA; Doubeni CA
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):145-152. PubMed ID: 33010408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mail-Based Self-Sampling to Complete Colorectal Cancer Screening: Accelerating Colorectal Cancer Screening and Follow-up Through Implementation Science.
    Gupta S; Barnes A; Brenner AT; Campbell J; Davis M; English K; Hoover S; Kim K; Kobrin S; Lance P; Mishra SI; Oliveri JM; Reuland DS; Subramanian S; Coronado GD
    Prev Chronic Dis; 2023 Dec; 20():E112. PubMed ID: 38060411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics.
    Davis SN; Christy SM; Chavarria EA; Abdulla R; Sutton SK; Schmidt AR; Vadaparampil ST; Quinn GP; Simmons VN; Ufondu CB; Ravindra C; Schultz I; Roetzheim RG; Shibata D; Meade CD; Gwede CK
    Cancer; 2017 Apr; 123(8):1390-1400. PubMed ID: 27906448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
    Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
    Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Text Messaging and Opt-out Mailed Outreach in Colorectal Cancer Screening: a Randomized Clinical Trial.
    Huf SW; Asch DA; Volpp KG; Reitz C; Mehta SJ
    J Gen Intern Med; 2021 Jul; 36(7):1958-1964. PubMed ID: 33511567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Patient-Directed Messaging on Colorectal Cancer Screening: A Randomized Clinical Trial.
    Oyalowo A; Forde KA; Lamanna A; Kochman ML
    JAMA Netw Open; 2022 Mar; 5(3):e224529. PubMed ID: 35357457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Finding the Right FIT": Rural Patient Preferences for Fecal Immunochemical Test (FIT) Characteristics.
    Pham R; Cross S; Fernandez B; Corson K; Dillon K; Yackley C; Davis MM
    J Am Board Fam Med; 2017; 30(5):632-644. PubMed ID: 28923816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study.
    Gordon NP; Green BB
    BMC Public Health; 2015 Jun; 15():546. PubMed ID: 26062732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual and Geospatial Characteristics Associated With Use and Nonuse of the Fecal Immunochemical Test (FIT) for Colorectal Cancer Screening in an Urban Minority Population.
    Ramai D; Etienne D; Ayide G; Fields PJ; Reddy M
    J Clin Gastroenterol; 2019; 53(10):744-749. PubMed ID: 30222644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.